List of Excipients in API valsartan and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing valsartan and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | DIOVAN HCT | valsartan and hydrochlorothiazide | 0078-0314 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | DIOVAN HCT | valsartan and hydrochlorothiazide | 0078-0314 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | DIOVAN HCT | valsartan and hydrochlorothiazide | 0078-0314 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | DIOVAN HCT | valsartan and hydrochlorothiazide | 0078-0314 | HYPROMELLOSES | |
| Novartis Pharmaceuticals Corporation | DIOVAN HCT | valsartan and hydrochlorothiazide | 0078-0314 | MAGNESIUM STEARATE | |
| Novartis Pharmaceuticals Corporation | DIOVAN HCT | valsartan and hydrochlorothiazide | 0078-0314 | POLYETHYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing valsartan and hydrochlorothiazide
Detailed excipient profiles for valsartan and hydrochlorothiazide
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
valsartan and hydrochlorothiazide drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | valsartan and hydrochlorothiazide | 68382-279 |
| Zydus Lifesciences Limited | valsartan and hydrochlorothiazide | 70771-1485 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
valsartan and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
valsartan and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
valsartan and hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
valsartan and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
valsartan and hydrochlorothiazide drug variants containing CROSPOVIDONE
valsartan and hydrochlorothiazide drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 1
valsartan and hydrochlorothiazide drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-6232 |
| Preferred Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 68788-8463 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
valsartan and hydrochlorothiazide drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | valsartan and hydrochlorothiazide | 43547-311 |
| Northwind Pharmaceuticals LLC | valsartan and hydrochlorothiazide | 51655-243 |
| Bryant Ranch Prepack | valsartan and hydrochlorothiazide | 71335-2200 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
valsartan and hydrochlorothiazide drug variants containing FD&C RED NO. 40
valsartan and hydrochlorothiazide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
valsartan and hydrochlorothiazide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-6232 |
| Northwind Pharmaceuticals LLC | valsartan and hydrochlorothiazide | 51655-243 |
| Preferred Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 68788-8463 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
valsartan and hydrochlorothiazide drug variants containing FERRIC OXIDE RED
valsartan and hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
valsartan and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
valsartan and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
valsartan and hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
valsartan and hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
valsartan and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-2640 |
| DirectRX | valsartan and hydrochlorothiazide | 61919-634 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 63187-428 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 71205-004 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
valsartan and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| DirectRX | valsartan and hydrochlorothiazide | 61919-634 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
valsartan and hydrochlorothiazide drug variants containing HYPROMELLOSE
valsartan and hydrochlorothiazide drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
valsartan and hydrochlorothiazide drug variants containing HYPROMELLOSE 2910
valsartan and hydrochlorothiazide drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
valsartan and hydrochlorothiazide drug variants containing HYPROMELLOSES
valsartan and hydrochlorothiazide drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
valsartan and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
valsartan and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
valsartan and hydrochlorothiazide drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-2640 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 63187-428 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 71205-004 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
valsartan and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
valsartan and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
valsartan and hydrochlorothiazide drug variants containing POLYDEXTROSE
valsartan and hydrochlorothiazide drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
valsartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
valsartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
valsartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 3350
valsartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
valsartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 400
valsartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
valsartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 4000
valsartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
valsartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 8000
valsartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
valsartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOLS
valsartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYVINYL ALCOHOL
valsartan and hydrochlorothiazide drug variants containing POLYVINYL ALCOHOL
valsartan and hydrochlorothiazide drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
valsartan and hydrochlorothiazide drug variants containing POVIDONE
valsartan and hydrochlorothiazide drug variants not containing POVIDONE
Excipient focus: SILICON DIOXIDE
valsartan and hydrochlorothiazide drug variants containing SILICON DIOXIDE
valsartan and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | valsartan and hydrochlorothiazide | 63187-312 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
valsartan and hydrochlorothiazide drug variants containing SODIUM LAURYL SULFATE
valsartan and hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
valsartan and hydrochlorothiazide drug variants containing STARCH, CORN
valsartan and hydrochlorothiazide drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
valsartan and hydrochlorothiazide drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | valsartan and hydrochlorothiazide | 57297-103 |
| Dispensing Solutions Inc | valsartan and hydrochlorothiazide | 68258-6969 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: TALC
valsartan and hydrochlorothiazide drug variants containing TALC
valsartan and hydrochlorothiazide drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
valsartan and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
valsartan and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
valsartan and hydrochlorothiazide drug variants containing TRIACETIN
valsartan and hydrochlorothiazide drug variants not containing TRIACETIN
Excipient focus: VANILLIN
valsartan and hydrochlorothiazide drug variants containing VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 0378-6321 |
| >Company | >Ingredient | >NDC |
valsartan and hydrochlorothiazide drug variants not containing VANILLIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
